Global pharma firms interested in local startup's new glaucoma treatment
Singapore
"FIRST you have my interest, now you have my attention."
And that is what local biotech startup Peregrine Ophthalmic managed to do, in the words of associate professor Tina Wong, who was describing how a new glaucoma drug delivery solution developed by her 15-month-old startup has attracted inquiries from the world's top five pharmaceutical companies.
TRENDING NOW
Singapore households’ net wealth up, but also taking on more debt such as home loans
With new S$10 million HQ, Jumbo Group looks to Shanghai-focused China strategy, premium dining for growth
Up to 11 new condo projects with 3,550 units lined up for H2 launch as price ceilings emerge
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned